Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOHAMMED A BARI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1679588370
CMS profile
121646
Location
NATIONAL CITY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$1,556.21

92 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,556.21 92

By paying entity

PY2020 · entire year · sorted by reported total

Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOHAMMED A BARI

NPI 1679588370 · CMS profile ID 121646

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

NATIONAL CITY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1679588370?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOHAMMED A BARI, NPI 1679588370, CMS profile ID 121646. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1679588370?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). MOHAMMED A BARI, NPI 1679588370, CMS profile ID 121646. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1679588370?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
MOHAMMED A BARI, NPI 1679588370, CMS profile ID 121646, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–92 of 92 matching records. This page contains 42 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1679588370?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

92 matching records · $1,556.21 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 92 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–92 of 92.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novo Nordisk Inc $20.4807/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744775861 CMS
Indivior Inc. $22.2407/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752765137 CMS
Vanda Pharmaceuticals Inc. $14.2007/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735125651 CMS
Sunovion Pharmaceuticals Inc. $3.0006/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748506533 CMS
Alkermes, Inc. $24.0806/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736961841 CMS
Lundbeck LLC $21.9106/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747501425 CMS
Alkermes, Inc. $14.4906/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736961843 CMS
Allergan, Inc. $19.0906/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723854325 CMS
Eisai Inc. $13.2706/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751208231 CMS
Alkermes, Inc. $16.3105/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736961845 CMS
Allergan, Inc. $6.2505/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723854323 CMS
Sunovion Pharmaceuticals Inc. $9.6305/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748506541 CMS
Vanda Pharmaceuticals Inc. $14.1205/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735125647 CMS
Alkermes, Inc. $23.2505/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736961839 CMS
Teva Pharmaceuticals USA, Inc. $16.6105/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749483499 CMS
Allergan, Inc. $18.0005/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723854321 CMS
Sunovion Pharmaceuticals Inc. $25.1605/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748506567 CMS
Vanda Pharmaceuticals Inc. $1.6704/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735125643 CMS
Vanda Pharmaceuticals Inc. $27.9904/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735125641 CMS
Sunovion Pharmaceuticals Inc. $22.3204/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748506563 CMS
Alkermes, Inc. $22.2904/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736961835 CMS
Vanda Pharmaceuticals Inc. $14.7804/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735125637 CMS
Teva Pharmaceuticals USA, Inc. $19.1803/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749484305 CMS
Alkermes, Inc. $23.8903/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736961837 CMS
Allergan, Inc. $11.0703/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723854319 CMS
Vanda Pharmaceuticals Inc. $13.5403/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735125635 CMS
Lundbeck LLC $13.0903/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747501421 CMS
Neurocrine Biosciences, Inc. $22.1403/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748913901 CMS
Allergan, Inc. $9.3802/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723854317 CMS
GlaxoSmithKline, LLC. $11.0602/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738777439 CMS
Sunovion Pharmaceuticals Inc. $16.4002/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748506545 CMS
Alkermes, Inc. $24.3702/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736961833 CMS
Neurocrine Biosciences, Inc. $14.9302/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748913895 CMS
Allergan, Inc. $4.6601/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723854315 CMS
Teva Pharmaceuticals USA, Inc. $14.9501/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749516869 CMS
Alkermes, Inc. $22.4401/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736961831 CMS
Neurocrine Biosciences, Inc. $15.6201/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748913893 CMS
Lundbeck LLC $22.9601/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747501417 CMS
Allergan, Inc. $5.1501/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723854313 CMS
Sunovion Pharmaceuticals Inc. $16.7501/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748506549 CMS
Neurocrine Biosciences, Inc. $13.7501/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748913887 CMS
Teva Pharmaceuticals USA, Inc. $14.4301/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749514877 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,378.60 68
PY2020 $1,556.21 92
PY2021 $2,400.35 135
PY2022 $2,887.15 136
PY2023 $2,995.43 120
PY2024 $4,285.18 141
PY2025 $5,695.45 223

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $50,036.28 5
PY2024 Principal investigator $249,579.99 37
PY2023 Recipient $26,675.92 5
PY2023 Principal investigator $767,555.49 236
PY2022 Recipient $450.00 1
PY2022 Principal investigator $252,704.64 57
PY2021 Recipient $52,585.60 4
PY2021 Principal investigator $919,160.99 151
PY2020 Principal investigator $2,113,013.58 219
PY2019 Principal investigator $1,400,000.51 227

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $1,997.99 05/22/2025 Non-covered Recipient Entity
Srsd Inc
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1228724654
Principal investigator 1 Sumitomo Pharma America, Inc. $45,748.90 03/03/2025 Non-covered Recipient Entity
SRSD INC
A 24-WEEK, OPEN-LABEL STUDY EVALUATING THE EFFECTIVENESS, SAFETY AND TOLERABILITY OF SEP-363856 IN SUBJECTS WITH SCHIZOPHRENIA SWITCHED FROM TYPICAL OR ATYPICAL ANTIPSYCHOTIC AGENTS OLE. No dispute reported 06/30/2026 1176629982
Principal investigator 1 Sumitomo Pharma America, Inc. $70.00 01/31/2025 Non-covered Recipient Entity
SYNERGY SAN DIEGO
A 24-WEEK, OPEN-LABEL STUDY EVALUATING THE EFFECTIVENESS, SAFETY AND TOLERABILITY OF SEP-363856 IN SUBJECTS WITH SCHIZOPHRENIA SWITCHED FROM TYPICAL OR ATYPICAL ANTIPSYCHOTIC AGENTS OLE. No dispute reported 06/30/2026 1176625105
Principal investigator 1 Sumitomo Pharma America, Inc. $221.40 01/17/2025 Non-covered Recipient Entity
SRSD INC
A 24-WEEK, OPEN-LABEL STUDY EVALUATING THE EFFECTIVENESS, SAFETY AND TOLERABILITY OF SEP-363856 IN SUBJECTS WITH SCHIZOPHRENIA SWITCHED FROM TYPICAL OR ATYPICAL ANTIPSYCHOTIC AGENTS OLE. No dispute reported 06/30/2026 1176624247
Principal investigator 1 PFIZER INC. $1,997.99 01/16/2025 Non-covered Recipient Entity
Srsd Inc
A PHASE 23 RANDOMIZED DOUBLEBLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL ZAVEGEPANT IN MIGRAINE PREVENTION No dispute reported 06/30/2026 1228765679